We have attached herewith intimation for record fixed for Annual General Meeting. Kindly take the same on your record. Thank you.

August 13, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Outcome of Board Meeting of ANLON HEALTHCARE LIMITED (“Company”) Respected Sir/Madam, Pursuant to Regulation 30 read with Part - A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Monday, August 13, 2026, at the Registered Office of the Company inter alia considered and approved the following matters: 1. The Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2026 together with the reports of the Board of Directors and Auditors thereon. 2. The Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2026 together with the reports of the Board of Directors and Auditors thereon. 3. Appointment a director in place of Mr. Punitkumar Rameshbhai Rasadia (Din: 06696258) who retires by rotation and being eligible, offers himself for re- appointment. The relevant details for the same are provided in Annexure A. 4. Regularization of Mr. Kishan Vinodkumar Raja (DIN: 11522235) as a Non-Executive & Independent Director. The relevant details for the same are provided in Annexure 5. Appointment of Mr. Parth Sanjaybhai Udani, Proprietor of M/s. P.S. Udani & Associates, Chartered Accountant as an Internal Auditor for the financial year 2026- 2027. The relevant details for the same are provided in Annexure C. 6. Approved remuneration of Cost Auditor of the Company. 7. Increase the authorized share capital of the Company from Rs.1,100,000,000/- (Rupees One Hundred and Ten Crore Only) to Rs.1,300,000,000 (Rupees One Hundred and Thirty Crore Only) and subsequent change in the capital clause of the Memorandum of Association of the Company subject to the approval of the shareholders of the Company at the forthcoming annual general meeting. 8. Adoption of 2 (two) share swap agreements both dated August 8, 2026, a entered by the Company with certain shareholders of Apiqo Organics Private Limited (“AOPL”) with the intention to acquire up to 44.94% shareholding in AOPL, and certain shareholders of Bizotic Lifescience Private Limited (“BLPL”) with the intention to acquire up to 47.41% shareholding in BLPL, and approval for issuance of 8,58,83,617 (Eight Crore Fifty-Eight Lakh Eighty-Three Thousand Six-Hundred Seventeen) Equity Shares of the Company on a preferential basis for consideration other than cash, to such identified shareholders of AOPL and BLPL, on an aggregate basis, in accordance ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in with the share exchange ratio of 1:14.45 for AOPL and 1:8.96 for BLPL, in lieu thereof, including rounding off to the nearest whole equity share for any fractional entitlement regarding of the decimal value. The specific details of these acquisitions are set out herein below: (a) the acquisition of up to 45,16,200 (Forty-Five Lakhs Sixteen Thousand Two Hundred) equity shares i.e. 44.94% equity shareholding of AOPL by the Company for a total purchase consideration of Rs.1,165,179,600/- (Rupees One Hundred Sixteen Crore Fifty-One Lakh Seventy-Nine Thousand Six-Hundred Only) at a price of Rs.258/- (Rupees Two Hundred Fifty-Eight Only) per equity share, which shall be discharged by the Company by way of issuance and allotment of up to 6,52,76,283 (Six Crore Fifty-Two Lakhs Seventy-Six Thousand Two Hundred And Eighty-Three) fully paid up equity shares of the Company having face value of Rs.02/- (Rupee Two Only) each at a price of Rs.17.85/- (Rupees Seventeen and Eighty-Five Paise Only) per equity share (including a security premium of Rs.15.85/- (Rupees Fifteen and Eighty Five Paise Only) per share, to such identified shareholders of AOPL, including promoters and non-promoters of the Company, for consideration other than cash on a preferential basis, on such terms and conditions as may be determined by the Board in accordance with the applicable laws; and (b) the acquisition of up to 22,99,000 (Twenty-Two Lakhs Ninety-Nine Thousand) equity shares i.e. 47.41% equity shareholding of BLPL by the Company for a total purchase consideration of Rs.367,840,000/- (Rupees Thirty-Six Crore Seventy Eight Lakhs Forty Thousand Only) at a price of Rs.160/- (Rupees One Hundred and Sixty Only) per equity share which shall be discharged by the Company by way of issuance and allotment of up to 2,06,07,334 (Two Crore Six Lakh Seven Thousand Three Hundred And Thirty-Four) fully paid-up equity shares of the Company having face value of Rs.02/- (Rupee Two Only) each at a price of Rs.17.85/- (Rupees Seventeen and Eighty-Five Paise Only) per equity share (including a security premium of Rs.15.85/- (Rupees Fifteen and Eight Five Paisa Only) per share, to such identified shareholders of BLPL, including promoters and non-promoters of the Company, for consideration other than cash on a preferential basis, on such terms and conditions as may be determined by the Board in accordance with the applicable laws. The relevant details in relation to this item are provided in Annexure D, Annexure E and Annexure F. 9. Material Related Party transactions between Apiqo Organics Private Limited and the Company. The relevant details for the same are provided in Annexure-G. 10. Material Related Party transactions between Bizotic Lifescience Private Limited and the Company. The relevant details for the same are provided in Annexure-H. 11. Material Related Party transactions between Anlon Medicos Private Limited (formerly known as Remember India Health Links Private Limited) and the Company. The relevant details for the same are provided in Annexure-I. 12. The Board of Directors has fixed the day, date, time and place for the forthcoming Annual General Meeting (“AGM”) of the Company. The Board decided that the Annual General Meeting of the Company will be held on Saturday, September 05, 2026 at 11:00 A.M. IST through through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’). 13. The Register of Members and Share Transfer Books shall remain closed from Saturday, August 29, 2026 to Friday, September 04, 2026 (both days inclusive). ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in 14. The e-voting period commences on Wednesday, September 02, 2026 (9:00 A.M. IST) and ends on Friday, September 04, 2026 (5:00 P.M. IST). 15. During this period members of the Company holding shares either in Physical form or in dematerialized form as of Friday, August 28, 2026 (cut-off date for E-voting) may cast their vote through remote e-voting. 16. The Board has appointed M/s. K.P. Ghelani & Associates, Company Secretaries as a Scrutinizer of the Company for conducting the e-voting process in Extra –Ordinary General Meeting. The relevant details pursuant to Schedule III of the SEBI Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the SEBI Listing Regulations by listed entities, bearing ref. no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, as annexed in Annexure A, Annexure B, Annexure C, Annexure D, Annexure E, Annexure F, Annexure G, Annexure H and Annexure I. Meeting commenced on 05:00 p.m. IST and concluded on 07:00 p.m. IST. You are requested to take the above information on your r [Showing first 8,000 characters — download PDF for full document]